Women's Fertility Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 39.4 billion
Estimated Base Value
2035 Forecast
US$ 83.5 billion
Projected Market Value
CAGR 2026–2035
7.8%
Compound Annual Growth
Largest Segment
In Vitro Fertilization (IVF) Services
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Middle East & Africa
Top Country
United States
By Market Share
Largest market
Key Players
TFP Fertility Group
Emerging Players
Kindbody, Carrot Fertility
Women's Fertility Market Overview
The Women's Fertility Market covers healthcare services and medical interventions designed to diagnose, treat, and support women experiencing infertility or seeking to preserve their fertility. This includes assisted reproductive technologies (ART), diagnostic testing, fertility preservation techniques, and pharmacological treatments aimed at facilitating conception and achieving successful pregnancy outcomes. The market caters to individual women and couples facing reproductive challenges, providing comprehensive medical and clinical solutions focused solely on female reproductive health.
The market is estimated at $39.4 Bn in 2025 and is forecast to reach $83.5 Bn in 2035, growing at a CAGR of 7.8% from 2025 to 2035. Demand is driven by increasing global infertility rates and technological advancements in ART, which improve success rates. Rising disposable income and growing insurance coverage also enhance market accessibility. High treatment costs, limited insurance coverage, ethical concerns, and variable success rates are factors that restrain market growth.
The market is segmented by Type, End-User, Technology, Stage, Application, and Source. Geographically, it is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, CCRM Fertility, Nova IVF Fertility, The Fertility Partners, IVF Lifecare, ART Fertility Clinics, Genea Fertility, Care Fertility, and Gennet. The full report provides a detailed analysis of these segments and regional dynamics.
Market Definition & Overview
The Women's Fertility Market encompasses the entire spectrum of healthcare services and medical interventions specifically designed to diagnose, treat, and support women experiencing infertility or seeking to preserve their fertility. This includes a range of assisted reproductive technologies (ART), diagnostic testing, fertility preservation techniques, and pharmacological treatments aimed at facilitating conception and achieving successful pregnancy outcomes. It caters to individual women and couples facing reproductive challenges, providing comprehensive medical and clinical solutions within the broader fertility industry, focusing solely on female reproductive health.
Scope
- Geographic: Global market analysis across all regions.
- Segment: Services targeting women and couples seeking female fertility solutions.
- Time-period: Current market conditions and a 10-year forecast horizon.
Inclusions
- In Vitro Fertilization (IVF) procedures for women.
- Intrauterine Insemination (IUI) services.
- Ovulation induction and monitoring treatments.
- Comprehensive diagnostic testing for female infertility.
- Egg freezing and oocyte cryopreservation services.
- Prescription fertility medications specifically for women.
Exclusions
- Male-specific fertility diagnostic and treatment services.
- General gynecological or obstetric care unrelated to fertility.
- Contraception or general family planning services.
- Surrogacy arrangements and related legal or medical services.
- Post-conception pregnancy care and childbirth services.
Market Size Forecast
Executive Summary
• The Women's Fertility market is valued at $39.4 Bn in 2025 and is forecast to reach $83.5 Bn by 2035, reflecting a robust CAGR of 7.8% as demand accelerates across every major segment and region over the ten-year outlook.
• In Vitro Fertilization (IVF) Services leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• China remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying private equity-backed consolidation is reshaping the competitive landscape, creating dominant regional players and exerting upward pressure on premium service pricing and market access dynamics globally.
• Key growth catalysts include significant advancements in assisted reproductive technologies, evolving societal norms around delayed childbearing, and expanding insurance coverage, driving demand across developed and emerging markets.
• Regulatory frameworks are adapting to genomic screening and AI applications, posing both opportunities for innovation and challenges for ethical oversight, impacting global market adoption strategies.
• Personalized fertility treatment and diagnostic segments are experiencing rapid expansion, necessitating targeted investment in clinical infrastructure and specialized personnel to address diverse regional patient needs.
• Investment capital is flowing towards innovative early-stage startups focused on non-invasive diagnostics and digital health platforms, signaling a shift in supply chain value creation and patient engagement models.
• The long-term outlook remains robust, driven by persistent demographic shifts and a growing emphasis on preventative reproductive health, compelling providers to diversify service offerings and expand geographic reach.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Women's Fertility Market was valued at $39.4 billion in the base year, establishing a significant foundation for future growth.
Robust Growth Outlook
The market is projected to achieve a value of $83.5 billion by the forecast year, demonstrating strong upward momentum.
Impressive CAGR
This substantial market expansion is driven by an impressive compound annual growth rate (CAGR) of 7.8% over the forecast period.
Significant Market Expansion
The nearly threefold increase from $39.4 billion to $83.5 billion highlights the profound expansion anticipated in fertility healthcare services.
Evolving Demand Drivers
A notable trend driving this growth includes increasing awareness, delayed pregnancies, and continuous advancements in assisted reproductive technologies.
Global Service Adoption
The strong growth trajectory suggests broad adoption of fertility services across diverse regions, indicating a globally expanding market.
Market Dynamics
Market Trends
- Delayed childbearing is increasingly common among women globally.
- Awareness and adoption of fertility preservation, like egg freezing, are rising.
- Personalized fertility treatment plans are becoming the industry standard.
- Telemedicine and virtual fertility consultations are experiencing significant growth.
Growth Drivers
- Increasing global infertility rates are boosting demand for solutions.
- Technological advancements in ART significantly improve success rates.
- Rising disposable income supports access to expensive fertility treatments.
- Growing insurance coverage and government support enhance market accessibility.
Restraints
- High treatment costs and limited insurance coverage restrict market accessibility.
- Ethical and religious concerns pose significant societal and individual adoption barriers.
- Variable success rates for procedures can deter patient investment and confidence.
- Navigating complex regulatory environments and legal frameworks remains challenging.
Opportunities
- Expansion into underserved emerging markets presents significant growth potential.
- Innovation in non-invasive diagnostics and less aggressive treatments is key.
- Leveraging AI and data for personalized treatment protocols offers new avenues.
- Developing holistic fertility wellness programs attracts a broader patient base.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | In Vitro Fertilization ServicesIntrauterine Insemination ServicesOocyte Cryopreservation ServicesEmbryo Cryopreservation ServicesFertility Diagnostics & Testing ServicesFertility Medication Management ServicesSurgical Fertility Treatment ServicesFertility Counseling & Support Services |
| By End-User | Infertile Heterosexual CouplesSingle Women Opting for ParenthoodWomen Seeking Elective Fertility PreservationWomen Undergoing Cancer TreatmentLGBTQ+ Individuals & CouplesWomen With Genetic Predispositions |
| By Technology | In Vitro Fertilization & Intracytoplasmic Sperm InjectionGamete & Embryo CryopreservationPreimplantation Genetic TestingHormonal Assay & Imaging DiagnosticsMinimally Invasive Surgical TechniquesOvulation Tracking & Fertility Monitoring DevicesArtificial Intelligence & Machine Learning in Embryo SelectionFertility Tracking Applications & Digital Platforms |
| By Stage | Diagnostic & Assessment StageTreatment & Intervention StageFertility Preservation StagePreconception & Planning StagePost Treatment & Follow Up StageFamily Building Support Stage |
| By Application | Infertility Treatment for WomenElective Fertility PreservationMedical Fertility PreservationPreimplantation Genetic TestingRecurrent Pregnancy Loss ManagementHormonal Imbalance TreatmentFamily Planning & Preconception Care |
| By Source | Autologous OocytesDonor OocytesPartner SpermDonor SpermDonor Embryos |
Regional Analysis
- North America dominates the women's fertility market, primarily driven by high disposable income, advanced technological adoption, and a robust network of fertility clinics. High awareness and a supportive regulatory environment further solidify its leading position.
- The Asia-Pacific region is the fastest-growing market, fueled by rising infertility rates, increasing healthcare expenditure, and growing awareness of fertility treatments. Expanding medical tourism and a surge in advanced fertility centers significantly contribute to this rapid growth.
- The Middle East and Africa show significant emerging potential, with increasing awareness and access to fertility services. Rising disposable incomes and a growing number of specialized clinics are driving demand, although cultural and religious factors continue to influence market development.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature and technologically advanced market, North America benefits from high awareness, favorable reimbursement policies, and a strong presence of key players.
- Delayed childbearing and lifestyle factors are primary drivers.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is experiencing steady growth driven by increasing awareness of infertility, improving access to advanced medical technologies, and rising disposable incomes in key economies.
- Evolving ethical and legal frameworks also play a role.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Europe represents a significant market with high demand for fertility treatments, supported by robust healthcare infrastructure and technological advancements.
- However, varying regulations and economic conditions across countries influence market dynamics.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region dominates the market due to its large population, rising infertility rates, increasing disposable incomes, and expanding access to fertility clinics.
- Government initiatives and medical tourism further fuel its growth.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A rapidly emerging market, driven by cultural factors, increasing disposable income, and improving healthcare infrastructure, particularly in urban centers.
- High unmet needs and a growing medical tourism sector contribute to its expansion.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The largest and most technologically advanced market, driven by delayed childbearing, increasing prevalence of infertility, and a robust private clinic infrastructure with evolving insurance coverage. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | The largest market in South America, fueled by a substantial population base, increasing disposable income, and a rising prevalence of infertility driving demand for ART services. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Benefits from a high-quality healthcare infrastructure, strong research and development in reproductive medicine, and a growing number of specialized fertility centers. |
| 4 | China | US$ XX.X Mn | XX.X% | The largest and fastest-growing market, driven by the easing of family planning policies, increasing prevalence of infertility, and substantial government and private investment in reproductive health. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | A market with high prevalence of infertility, increasing disposable income, and significant government investments in advanced healthcare infrastructure driving demand for fertility services. |
Countries Covered (26)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Russia, Rest of Europe, China, India, Japan, South Korea, Australia, Taiwan, Singapore, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | TFP Fertility Group | XX.X% | Consolidate and grow its presence in the European fertility market by acquiring and integrating leading local clinics. | — | — | IVFICSIEgg Freezing+1 |
| 2 | US Fertility | XX.X% | Build a dominant national network of fertility practices in the United States by partnering with and investing in established local clinics. | — | — | IVFEgg FreezingIntrauterine Insemination+1 |
| 3 | Virtus Health | XX.X% | Focus on leadership in Australasia while pursuing targeted international expansion, emphasizing research and innovation. | — | — | IVFFertility PreservationDonor Services+1 |
| 4 | Monash IVF Group | XX.X% | Grow its presence in Australia and Southeast Asia by offering a comprehensive range of fertility treatments and investing in new technologies. | — | — | IVFICSIEgg Freezing+1 |
| 5 | CCRM Fertility | XX.X% | Deliver best-in-class fertility outcomes through proprietary research, advanced technologies, and individualized patient care. | — | — | IVFEgg FreezingGenetic Testing+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (19)
TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, CCRM Fertility, Nova IVF Fertility, The Fertility Partners, IVF Lifecare, ART Fertility Clinics, Genea Fertility, Care Fertility, Gennet, Bourn Hall Clinic, Repromeda (Czech Republic), Fertility Associates, Bloom IVF Group, ReproMed Ireland, Dunya IVF, CREATE Fertility
The global Women's Fertility market features a competitive landscape led by IVI-RMA Global, TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, and CCRM Fertility, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
TFP Fertility Group
US Fertility
Virtus Health
Monash IVF Group
CCRM Fertility
Nova IVF Fertility
The Fertility Partners
IVF Lifecare
ART Fertility Clinics
Genea Fertility
Care Fertility
Gennet
Bourn Hall Clinic
Repromeda (Czech Republic)
Fertility Associates
Bloom IVF Group
ReproMed Ireland
Dunya IVF
CREATE Fertility
Kindbody
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
AI-Powered Embryo Selection Tool Gains Wider European Adoption
Presagen's Life Whisperer Viability and Life Whisperer Genetics, AI-driven embryo assessment tools, received CE Mark and UKCA Mark, paving the way for expanded use across European fertility clinics. This enhances precision in IVF embryo selection.
Kindbody Announces Strategic Expansion with Multiple New Clinic Openings
Leading fertility and family-building benefits provider Kindbody revealed plans for significant clinic network expansion, including new full-service clinics in key U.S. markets. This move aims to improve access to comprehensive fertility care nationwide.
Alife Health Secures US$ XX.X Series B for AI-Driven IVF Software
Alife Health, a company developing AI solutions to optimize IVF outcomes, successfully closed a US$ XX.X Series B funding round. The investment will accelerate product development and commercialization of its AI platform for fertility clinics.
Progyny Expands Employer Network, Boosting Fertility Benefit Access for Millions
Progyny, a leading fertility and family building benefits provider, announced a significant expansion of its employer network, bringing comprehensive fertility coverage to millions of additional employees. This broadens access to high-quality care, including IVF and genetic testing.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $39.4 Bn |
| Market Size (Forecast) | $83.5 Bn |
| CAGR | 7.8% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 26 Countries |
| Segments Covered | 6 Segments, 40 Sub-segments |
| Companies Profiled | 31 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Women's Fertility Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The Women's Fertility market is estimated at $39.4 Bn in 2025. It is forecast to reach $83.5 Bn in 2035.
The Women's Fertility market is forecast to grow at a CAGR of 7.8% from 2025 to 2035.
The main segments are by Type, End-User, Technology, Stage, Application, and Source. These include In Vitro Fertilization Services, Infertile Heterosexual Couples, and In Vitro Fertilization & Intracytoplasmic Sperm Injection.
Leading companies include TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, CCRM Fertility, Nova IVF Fertility, The Fertility Partners, IVF Lifecare, ART Fertility Clinics, Genea Fertility, Care Fertility, and Gennet.
The report covers the entire spectrum of healthcare services and medical interventions for diagnosing, treating, and supporting women's fertility. It includes assisted reproductive technologies, diagnostic testing, fertility preservation, and pharmacological treatments across various segments and regions.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Women's Digital Health Market
$5.7 Bn in 2025 · 15.7% CAGR
AI Fertility Platform Market
$500.0 Mn in 2025 · 19.2% CAGR
Digital Women's Health Platform Market
$7.7 Bn in 2025 · 17.1% CAGR
AI Clinical Monitoring Market
$3.0 Bn in 2025 · 19.4% CAGR
AI Medical Scribing Market
$1.4 Bn in 2025 · 24.8% CAGR
Clinical Trials Market
$60.6 Bn in 2025 · 7.5% CAGR
Companion Animal Healthcare Market
$35.3 Bn in 2025 · 11.3% CAGR
Connected Home Care Market
$12.7 Bn in 2025 · 15.8% CAGR